Gain of function of mutant p53 by coaggregation with multiple tumor suppressors

Protein complexes/aggregates as potential cancer biomarkers revealed by a nanoparticle aggregation immunoassay

(2010) Qun Huo   COLLOIDS AND SURFACES B-BIOINTERFACES

The role of mutant p53 in human cancer

(2010) Amanda M Goh et al.   JOURNAL OF PATHOLOGY

TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs

(2010) Xiaohua Su et al.   NATURE

Protein aggregation diseases: pathogenicity and therapeutic perspectives

(2010) Adriano Aguzzi et al.   NATURE REVIEWS DRUG DISCOVERY

Drug discovery and mutant p53

(2010) Magda M. Maslon et al.   TRENDS IN CELL BIOLOGY

Structural biology of the p53 tumour suppressor

(2009) Andrei L Okorokov et al.   CURRENT OPINION IN STRUCTURAL BIOLOGY

Structural evolution of p53, p63, and p73: Implication for heterotetramer formation

(2009) A. C. Joerger et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Structural Biology of the Tumor Suppressor p53

(2008) Andreas C. Joerger et al.   Annual Review of Biochemistry

MSL2 Promotes Mdm2-independent Cytoplasmic Localization of p53

(2008) Jan-Philipp Kruse et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Molecular chaperones as regulators of cell death

(2008) A Hishiya et al.   ONCOGENE